Pfizer, BioNTech launch COVID-19 vaccine trial in kids under 12
By Michael Erman (Reuters) - Pfizer Inc and German partner BioNTech SE began testing their COVID-19 vaccine in children under 12, with hopes of expanding vaccination to that age range by early 2022, the U.S.
COVID-19 vaccine trial in kids under 12" src="https://images.firstpost.com/wp-content/uploads/reuters/03-2021/26/2021-03-25T173231Z_1_LYNXMPEH2O1KC_RTROPTP_2_HEALTH-CORONAVIRUS-VACCINE.jpg" alt="Pfizer BioNTech launch COVID19 vaccine trial in kids under 12" width="300" height="225" />
By Michael Erman
(Reuters) - Pfizer Inc and German partner BioNTech SE began testing their COVID-19 vaccine in children under 12, with hopes of expanding vaccination to that age range by early 2022, the U.S. drugmaker said on Thursday.
The first volunteers in the early-stage trial were given their first injections on Wednesday, Pfizer spokesperson Sharon Castillo said.
The Pfizer/BioNTech vaccine was authorized by U.S. regulators in late December for people age 16 and older. Nearly 66 million doses of the vaccine had been administered in the United States as of Wednesday morning, according to data from the U.S. Centers for Disease Control and Prevention.
The pediatric trial, which will include children as young as 6 months, follows a similar one launched by Moderna Inc last week.
Only the Pfizer/BioNTech vaccine is being used in 16- and 17-year-olds in the United States. Moderna's shot was cleared for those age 18 and older, and no COVID-19 vaccine has been authorized in younger kids yet.
Pfizer and BioNTech plan to initially test the safety of their two-shot vaccine at three different dosages - 10, 20 and 30 micrograms - in a 144-participant Phase I/II trial.
They plan to later expand to a 4,500-participant late-stage trial in which they will test the safety, tolerability and immune response generated by the vaccine, likely by measuring antibody levels in the young subjects.
Castillo said the companies hope to have data from the trial in the second half of 2021.
Meanwhile, Pfizer has been testing the vaccine in children from age 12 to 15. The company expects to have data from that trial in the coming weeks, Castillo said.
(Reporting by Michael Erman; Additional reporting by Julie Steenhuysen in Chicago; Editing by Bill Berkrot)
This story has not been edited by Firstpost staff and is generated by auto-feed.
CARACAS (Reuters) - Human rights groups from Venezuela and Colombia on Wednesday called on the United Nations to appoint a special envoy to address the humanitarian crisis caused by clashes between Venezuelan troops and Colombian armed groups near the countries' border. Colombian officials estimate that some 4,000 people have fled Venezuela for Colombia since March 21 following a military offensive in Venezuela's Apure state.
By Anton Zverev and Andrew Osborn MOSCOW (Reuters) - Jailed Kremlin critic Alexei Navalny went on hunger strike on Wednesday in an attempt to force the prison holding him outside Moscow to provide him with proper medical care for what he said was acute pain in his back and legs. The fate of Navalny, one of President Vladimir Putin's most prominent critics, is in focus after he said last week that being woken up by a guard every hour during the night amounted to torture and that his appeals for medical treatment had been ignored. In a handwritten letter addressed to the governor of his prison which was posted to social media by his team on Wednesday, Navalny said daily requests for a doctor of his choice to examine him and for proper medicine had been ignored
By Stephanie van den Berg THE HAGUE (Reuters) - The International Criminal Court on Wednesday upheld its 2019 acquittal of former Ivory Coast President Laurent Gbagbo on charges of crimes against humanity during post-election violence and ordered all conditions of his release be removed. The decision may open the way for Gbagbo, 75, who has been living in Belgium, to return to Ivory Coast